Library

Etoxadrol

Etoxadrol is a dioxolane NMDA antagonist developed as a dissociative anesthetic; unlike arylcyclohexylamines (PCP/ketamine), it features a 1,3-dioxolane piperidine scaffold. Clinical work shows IV 0.75 mg/kg yields anesthesia averaging 26 minutes (14-53 minutes) with active airway reflexes but raised heart rate/blood pressure and tachypnea. Prominent post-dose phenomena include alternating nystagmus lasting hours and vivid dream-like states; approximately 20% of patients reported unpleasant or threatening dreams persisting up to 24 hours. One overdose case at 4.65 mg/kg caused catalepsy, amnesia, and analgesia lasting 6 days. Binding studies place etoxadrol as a high-affinity PCP-site channel blocker at NMDA receptors (Ki = 107 nM), explaining PCP-like behavioral effects and animal self-administration.

Etoxadrol molecular structure
Etoxadrol molecular structure diagram from the DrugsPRO substance library.

Also known as: Cl-1848c, U-37862a

Classification

  • Psychoactive: Dissociative
  • Tag: Dioxolane piperidine dissociative
  • Tag: Hallucinogen
  • Tag: Other dissociative
  • Tag: Research-Chemical

Effects

  • Analgesia
  • Nystagmus
  • Tachycardia
  • Nausea
  • Pain Relief
  • Vomiting
  • Amnesia
  • Dissociation
  • Depersonalization
  • Time Distortion
  • Confusion
  • Anxiety
  • Dreamlike Imagery
  • Tactile Suppression
  • Double Vision
  • Open Eye Visuals
  • Visual Disconnection
  • Disinhibition

Routes of Administration

Intravenous (Clinical Use only)

Dosage

  • Threshold: ~0.2 mg/kg
  • Light: 0.3-0.5 mg/kg
  • Common: 0.6-0.9 mg/kg
  • Strong: 1.0-1.5 mg/kg
  • Heavy: 2.0 mg/kg

Duration

  • Offset: 0.25-1 h
  • After Effects: 18-24 h

Intravenous

Dosage

  • Heavy: ≥2.0 mg/kg
  • Light: 0.3–0.5 mg/kg
  • Common: 0.6–0.9 mg/kg
  • Strong: 1.0–1.5 mg/kg
  • Threshold: ~0.2 mg/kg

Duration

  • Onset: 0.1-1 h
  • Peak: 0-10 h
  • Offset: 15-60 h
  • After Effects: 60-1440 h
  • Total Duration: 14-53 h

Harm Reduction

Check interactions before mixing substances, pay attention to dose spacing and hydration, and treat all dosage guidance as approximate rather than guaranteed safe.

Sources

Substance data is aggregated from the following public harm-reduction and reference sources.

Links

This static page is intended as a readable non-JS and prerender-friendly library export.

Get the full DrugsPRO experience

Open the interactive DrugsPRO app for search, saved items, interactions, and deeper harm reduction tools.

Get the PRO test kit. The simple, quick and reliable drug checking test kit. Visit https://protestkit.eu

Etoxadrol - DrugsPRO stoffveiledning

Etoxadrol: Etoxadrol is a dioxolane NMDA antagonist developed as a dissociative anesthetic; unlike arylcyclohexylamines (PCP/ketamine), it features a 1,3-dioxolane piperidine scaffold. Clinical work shows IV 0.75 mg/kg yields anesthesia averaging 26 minutes (14-53 minutes) with active airway reflexe

Related pages